Fundraising Fox
/Companies
Sign in

Procyrion

Houston, US · Founded 2019 · 5 known investors

Find your way into Procyrion

Sign up to see every warm intro you have to Procyrion

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Procyrion team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Procyrion develops medical devices for circulatory support in heart failure treatment, supported by a team of cardiologists and medical device industry veterans.

BiotechHealthtechMedical Devices

Founders & leadership

Procyrion was founded in 2019 by Reynolds, III M. Delagado, Benjamin A. Hertzog, and Dr. Fain.

RI
Reynolds, III M. DelagadoCo-founder
BA
Benjamin A. HertzogCo-founder
DF
Dr. FainFounder/Executive
JJ
Jason J HeuringExecutive
BE
Bryan E. NearnVice President

Board

LI
Leo III E LinbeckBoard director
BO
Brian OliverPresident of Sole Manager
SO
Steve OldhamBoard director

Investors · 5

Scientific Health Developmentlisted by Scientific Health DevelopmentDallas · $2M

How we know: funding news · Not right? Tell us

Texas Ventureslisted by Texas VenturesHoustonvia E. Scott Crist · inferred
Fannin Goldenrod HoldingsinferredHouston

How we know: board seat on SEC Form D · Not right? Tell us

Also in the syndicate · 1

Fannin Partnerslead

Reported raises · per SEC filings

Form D private placements

$109.5M disclosed across 5 of 6 rounds · 2012–2023

▶$57.7MraisedFeb 2024 · 24 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeff BirdDirector
  • Marc P ChaputDirector
  • Jason HeuringExecutive Officer
  • Gerhard F BurbachDirector
  • Eric FainExecutive Officer, Director
  • Leo E Linbeck, IIIDirector
  • J. Carter MeyerDirector
Offering amount
$64M
Amount sold
$57.7M
First sale
Dec 2023
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$30MraisedJul 2019 · 12 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeff BirdDirector
  • Eric FainExecutive Officer, Director
  • Jason HeuringExecutive Officer
  • J. Carter MeyerDirector
  • Gerhard F BurbachDirector
  • Leo E Linbeck, IIIDirector
  • Marc P ChaputDirector
Offering amount
$30M
Amount sold
$30M
First sale
Jun 2019
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$16MraisedJan 2018 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Leo E Linbeck, IIIDirector
  • J. Carter MeyerDirector
  • Marc P ChaputDirector
  • Jason HeuringExecutive Officer
  • Gerhard F BurbachDirector
  • Benjamin A. HertzogExecutive Officer, Director
Offering amount
$16M
Amount sold
$16M
Proceeds to insiders
$1.6M
First sale
Jan 2018
Incorporated
Corporation, Texas
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.2MraisedJul 2015 · 16 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Reynolds, III M. DelagadoDirector
  • Steve OldhamDirector
  • Leo III E LinbeckDirector
  • Benjamin A HertzogExecutive Officer, Director
  • Jason J HeuringExecutive Officer
Offering amount
$10M
Amount sold
$5.2M
Minimum investment
$25K
Proceeds to insiders
$380K
First sale
Jun 2015
Incorporated
Corporation, Texas
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$650KraisedDec 2014 · 9 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Reynolds M. Delgado IIIDirector
  • Benjamin A. HertzogExecutive Officer, Director
  • Stephen OldhamDirector
  • Leo E. Linbeck IIIDirector
Offering amount
$650K
Amount sold
$650K
Minimum investment
$25K
Proceeds to insiders
$113.3K
First sale
Nov 2014
Incorporated
Corporation, Texas
Federal exemptions
04, 06b
Full filing on SEC EDGAR ↗
▶$2.5MofferedFeb 2012 · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Benjamin A. HertzogExecutive Officer
  • Bryan E. NearnExecutive Officer
  • Brian OliverExecutive Officer
Offering amount
$2.5M
Minimum investment
$50K
Incorporated
Corporation, Texas
Federal exemptions
06
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Procyrion Closes $57.7 Million in Series E Financingprnewswire.com · Feb 2024

Frequently asked questions

What does Procyrion do?
Procyrion develops medical devices for circulatory support in heart failure treatment, supported by a team of cardiologists and medical device industry veterans.
Who founded Procyrion?
Procyrion was founded by Reynolds, III M. Delagado, Benjamin A. Hertzog, Dr. Fain in 2019.
Who are Procyrion's investors?
Procyrion's investors include Bluebird Ventures, Scientific Health Development, Texas Ventures, Fannin Goldenrod Holdings.
How much funding has Procyrion raised?
Procyrion has disclosed $109.5M raised across 5 of its 6 known rounds.
Where is Procyrion headquartered?
Procyrion is headquartered in Houston, US.